Heading to Hamburg for ESGCT 2026
Joining the international cell and gene therapy community in Hamburg as a Silver Sponsor
From October 27 to 30, we will be in Hamburg for the ESGCT Annual Congress, connecting with the international cell and gene therapy community at the Congress Center Hamburg.
The Congress is being held in collaboration with @DG-GT and it is said to be “an invaluable platform for sharing the latest research, advancements and innovations in the field.”
As a Silver Sponsor, we will be at Booth E-15, where our team will be available to discuss current challenges and explore how our expertise in lentiviral vector development and manufacturing can address specific needs for both ex vivo and in vivo applications.
As part of the scientific programme, we will also present our latest scientific contribution, Poster P0825, entitled “EvoLVcell: A Producer Cell Line Platform for Scalable, Transfection-Free, and High-Quality Lentiviral Vector Manufacturing.”
The poster will be presented on October 28, from 1:30 to 3:30 PM, offering the opportunity to learn more about EvoLVcell and our approach to scalable, transfection-free lentiviral vector manufacturing.
If you are attending ESGCT 2026, visit us at Booth E-15 in Hamburg to meet our team and learn more about our lentiviral vector development and manufacturing capabilities.
